Rezolute, Inc. — Form 10-K
Filed September 24, 2026 · analyzed by the Periodic Agent
10-K
— Neutral
significance 18/100
What the filing says
Rezolute disclosed outstanding warrant positions across four tranches of pre-funded warrants issued 2021-2025 (totaling ~17.4M shares underlying, with ~9.7M exercised and ~7.7M unexercised as of Sept 24, 2026) plus participating warrants from Oct 2020 (820,001 shares, $19.50 exercise price, unexercised). Exercise prices on pre-funded warrants range $0.001–$0.01; participating warrants at $19.50. All warrants contain anti-dilution and fundamental transaction protections. This is a standard capital structure disclosure exhibit in the 10-K.
Why this rating
Routine securities description required by SEC; no new issuance, transaction, or material change. Warrant portfolio is significant dilution vector (~7.7M unexercised pre-funded shares at ~$260M market cap = ~2.9% immediate dilution risk), but disclosure itself is standard administrative filing content.
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.